CAR-T 细胞治疗在新型抗原靶点中前 30 天的感染并发症
Infectious complications of CAR T-cell therapy across novel antigen targets in the first 30 days.
46.9分
★★★☆☆
站内排序·非疗效
FRONTIER PAPERS
Infectious complications of CAR T-cell therapy across novel antigen targets in the first 30 days.
Expanding the Therapeutic Reach of Chimeric Antigen Receptor T-Cells and Bispecific T-Cell Engagers Across Solid Tumors.
Current and future perspectives of chimeric antigen receptors against glioblastoma.
共 3 条
MEMBER ACCOUNT
登录成功会直接打开下一页。